IMUX – immunic, inc. (US:NASDAQ)

News

Immunic (IMUX) was given a new $2.50 price target by Stifel Nicolaus.
Immunic (IMUX) was downgraded by D. Boral Capital from "buy" to "hold".
Immunic to Participate in Scientific and Medical Conferences in April [TheStreet.com]
Immunic to Participate in Scientific and Medical Conferences in April
Immunic regains compliance with Nasdaq minimum bid price requirement [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com